Blog

Have You Used Oral Steroids For Asthma?

Oral corticosteroids (steroids) are used to treat inflammation and suppress the immune system. Sometimes people take oral corticosteroids to treat asthma. What do you know about this treatment? We want to hear about your experiences with oral corticosteroids – like prednisone – for asthma. If you are an adult with asthma, please take our quick survey : TAKE THE SURVEY NOW The survey closes on June 30, 2018. We will use the information gathered from this survey to advocate on behalf of...

Play-In for Climate Action to Bring Attention to the Negative Effects of Poor Air Quality

On July 11, 2018, moms and their children will host the fifth annual Play-In for Climate Action. The Asthma and Allergy Foundation of America (AAFA) will join Moms Clean Air Force on the U.S. Capital Grounds in Washington, D.C., to support action against climate change. The family-friendly event will have kids’ activities, music and speakers.

Health Care Rule That Could Affect Those With Chronic Conditions Is Finalized

The Trump Administration released a final rule expanding the scope and applicability of association health plans (AHPs). The Department of Labor’s rule implements President Trump’s October 2017 executive order which directed agencies to change existing regulations to provide consumers with more options for health care coverage.

How to Raise Awareness About Asthma in Your Workplace

I am very honored to have been chosen by the Asthma and Allergy Foundation of America (AAFA) to be one of their featured interviews to help kick off National Asthma and Allergy Awareness Month. Please join me and thousands of others to raise awareness for asthma and help educate those around us who don’t live with the disease. The more we all understand it and are mindful of the people around us with this invisible disability, the better off we all will be.

Study Shows Mepolizumab to Be a Safe and Effective Long-Term Treatment Option for Severe Asthma

The Asthma and Allergy Foundation of America is sharing this press release from GlaxoSmithKline to bring you the latest research news quickly. [PRESS RELEASE] Nucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control New study showed one third of patients had no exacerbations on long-term treatment with Nucala GlaxoSmithKline plc (GSK) today presented new data from the longest study of an anti-IL5 biologic treatment in severe...

Three Bills Could Have a Big Impact on People With Asthma and Allergies

May is National Asthma and Allergy Awareness Month . During this month, our community seeks to raise greater awareness with family, friends, coworkers and others about what it is like to live with asthma and allergies. It’s also a good time to engage with your elected officials in Congress about several pieces of legislation that improve access to asthma and allergy treatments and medicines, and protect the rights of our patient community. The Asthma and Allergy Foundation of America (AAFA)...

×
×
×
×